BlueBird Bio Soars Off Potential Drug Approval

Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show.
'' Blue Bird Bio Inc. (NASDAQ:
BLUE
Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.